Page 4 - Les meilleurs doctors traitant la maladie suivante : Cancer de l'utérus - TOP -101 des médecins

Le professeur Gilad Ben Baruch est spécialisé en oncogynécologie au centre médical Assuta.

• Expert dans le traitement du cancer de l'utérus
• Spécialisé en oncologie gynécologique
• Travaille dans un centre médical de premier plan

Spécialisée en radiothérapie pour le cancer de l'utérus – Svetlana Zalmanova est radiothérapeute au centre médical Assuta.

• Se concentrer sur l'administration de traitements de radiothérapie précis

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Le Dr Amit Amnon est spécialisé en oncogynécologie au centre médical Rambam, se concentrant sur les traitements avancés du cancer de l'utérus.

• Se spécialiser en obstétrique, gynécologie et oncogynécologie
• Travailler au centre médical Rambam
• Se concentrer sur les traitements avancés du cancer de l'utérus

Spécialiste de la radiothérapie anticancéreuse – Le Dr Van Kampen traite ses patients selon cette méthode clé à la clinique Nordwest.

• Concentrer son expertise sur la radio-oncologie
• Travailler au sein d'un grand établissement hospitalier multidisciplinaire
• Fournir une approche ciblée pour le traitement des tumeurs

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.

Dr. Hisham Khalifa is a Consultant Surgical Oncologist. He assesses, diagnoses, and operates on gynecological cancers, including ovarian, uterine, cervical, vaginal, and vulval cancers. He performs both minimally invasive (laparoscopic) and open surgery.

Career milestones: Resident and faculty member at the National Cancer Institute, Cairo University (2001–2014). Assistant Professor at AlFaisal University and Assistant Consultant at King Faisal Hospital and Research Center (KFSHRC), Riyadh (2014–2019). Consultant at the NCI, Cairo (2019–present); Director of the Professional Diploma in Gyne-Onco Surgery. Consultant at the Oncology Pediatric Hospital–Alexandria University and Shefa Al Orman Comprehensive Cancer Center, Luxor (2020–present).

Credentials: MBBCh (1999); Master’s in General Surgery (2004); Doctorate in Surgical Oncology (2008); Fellowship of the European Board of Surgery (FEBS, UEMS). Memberships: FACS; SSO; ESSO; ECS; EGSSO.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Professeur et chef du service d'obstétrique et de gynécologie à la Clinique Nordwest, spécialisé dans les cas oncologiques.

• Expert en oncologie gynécologique avec une vaste expérience
• Diriger un département spécialisé à la Clinique Nordwest
• Se concentrer sur les soins oncologiques complets

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Le professeur Ami Fishman est spécialisé dans les chirurgies endoscopiques et laparoscopiques du cancer de l'utérus au Herzliya Medical Center.

• Oncogynécologue et chirurgien de premier plan au Herzliya Medical Center
• Chef du département d'obstétrique et de gynécologie au Meir Medical Center
• Expert en techniques mini-invasives pour l'oncologie gynécologique

Le professeur associé Serap Kaya est spécialisé dans le traitement du cancer de l'utérus avec une vaste expérience en oncologie médicale.

• Formation à la faculté de médecine de l'université de Marmara
• Spécialisation à l'hôpital de formation et de recherche Kartal Dr Lütfi Kırdar
• Sous-spécialité en oncologie médicale de l'université de Kocaeli
• Travail à l'hôpital de formation et de recherche Marmara University Pendik

Auteur de plus de 30 articles scientifiques sur le traitement du cancer, le Dr Derin est un nom de premier plan parmi les oncologues turcs et européens.

• Se spécialiser dans le cancer de l'utérus au sein de sa pratique des néoplasies gynécologiques
• Professeur agrégé disposant d'une vaste expérience clinique et académique
• Membre de l'European Society for Medical Oncology et d'associations d'oncologues turcs
• Oncologue en chef à l'hôpital Liv, une institution de premier plan pour les soins contre le cancer

Spécialisé en chirurgie laparoscopique et en oncologie, le Dr Abu Shamsiya a réalisé 1 100 interventions avec 25 ans d'expérience.

• Chef du département de chirurgie de la clinique Spizhenko
• Membre de l'Association ukrainienne des chirurgiens bariatriques et de l'IFSO
• Traiter les maladies oncologiques de la cavité abdominale et de l'espace rétropéritonéal
• Parle couramment l'anglais et l'arabe

Spécialiste des opérations laparoscopiques pour le cancer de l'utérus – le Dr Lee Kwang Beom apporte son expertise ciblée aux techniques mini-invasives.

• Oncogynécologue avec formation spécialisée
• Réaliser des procédures laparoscopiques avancées
• Affilié au Gachon University Gil Medical Center

Le Dr Sahibov est spécialisé en radio-oncologie pour le cancer de l'utérus, formé dans le cadre du programme réputé de l'université de Marmara.

• Avoir suivi une formation de spécialisation rigoureuse de 2012 à 2016
• 7 ans d'études médicales fondamentales dans une institution de premier plan
• Expertise ciblée sur les radiothérapies modernes